Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedMay 22, 2025
DataAggregated Company Financials
Companies16
  • 7D4.9%
  • 3M-5.7%
  • 1Y-12.2%
  • YTD1.4%

Over the last 7 days, the Pharma industry has risen 2.9%, driven by gains from AstraZeneca of 4.7%. During this same period, the ImmuPharma underperformed, falling 17%. In the past year, the industry is down 13%. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 22 May 2025UK£264.7bUK£86.7bUK£10.7b27x24.8x3.1x
Sat, 19 Apr 2025UK£252.1bUK£86.5bUK£9.6b26.7x26.3x2.9x
Mon, 17 Mar 2025UK£290.1bUK£87.7bUK£9.6b28.8x30.2x3.3x
Wed, 12 Feb 2025UK£282.5bUK£89.5bUK£9.5b30.5x29.6x3.2x
Fri, 10 Jan 2025UK£233.1bUK£76.3bUK£7.9b32.1x29.5x3.1x
Sun, 08 Dec 2024UK£227.6bUK£74.8bUK£7.7b32.1x29.5x3x
Tue, 05 Nov 2024UK£236.4bUK£72.5bUK£7.6b31.1x31.3x3.3x
Thu, 03 Oct 2024UK£252.6bUK£71.6bUK£9.0b30.4x28.2x3.5x
Sat, 31 Aug 2024UK£280.9bUK£72.0bUK£9.0b42x31.3x3.9x
Mon, 29 Jul 2024UK£259.8bUK£72.2bUK£9.6b34.8x27.2x3.6x
Wed, 26 Jun 2024UK£267.3bUK£71.6bUK£9.6b30.2x28x3.7x
Fri, 24 May 2024UK£272.7bUK£71.6bUK£9.6b32.7x28.5x3.8x
Sun, 21 Apr 2024UK£244.3bUK£71.6bUK£9.8b31.8x24.9x3.4x
Tue, 19 Mar 2024UK£236.4bUK£70.4bUK£9.7b31.9x24.3x3.4x
Thu, 15 Feb 2024UK£225.5bUK£69.9bUK£9.6b34.6x23.4x3.2x
Sat, 13 Jan 2024UK£244.2bUK£68.8bUK£10.7b37.2x22.9x3.5x
Mon, 11 Dec 2023UK£226.9bUK£69.4bUK£10.7b33.4x21.1x3.3x
Wed, 08 Nov 2023UK£230.2bUK£70.6bUK£11.0b52.9x20.9x3.3x
Fri, 06 Oct 2023UK£243.3bUK£70.7bUK£10.4b74.9x23.3x3.4x
Sun, 03 Sep 2023UK£236.9bUK£69.4bUK£10.2b53.5x23.2x3.4x
Tue, 01 Aug 2023UK£243.7bUK£68.4bUK£10.1b52.3x24x3.6x
Thu, 29 Jun 2023UK£243.4bUK£68.0bUK£7.9b55.5x30.8x3.6x
Sat, 27 May 2023UK£251.7bUK£68.9bUK£8.0b55.5x31.5x3.7x
Mon, 24 Apr 2023UK£262.0bUK£69.2bUK£6.9b63.2x38.2x3.8x
Wed, 22 Mar 2023UK£238.3bUK£69.9bUK£6.9b54.3x34.5x3.4x
Fri, 17 Feb 2023UK£248.1bUK£70.5bUK£7.4b41.2x33.6x3.5x
Sun, 15 Jan 2023UK£252.3bUK£79.6bUK£6.3b39x40x3.2x
Tue, 13 Dec 2022UK£246.5bUK£79.5bUK£6.3b37.3x39.1x3.1x
Thu, 10 Nov 2022UK£240.9bUK£80.6bUK£3.6b21.1x67.2x3x
Sat, 08 Oct 2022UK£220.0bUK£81.3bUK£3.6b19.5x60.3x2.7x
Mon, 05 Sep 2022UK£231.4bUK£79.6bUK£3.7b15x62.3x2.9x
Wed, 03 Aug 2022UK£249.0bUK£77.5bUK£3.8b16.6x65.1x3.2x
Fri, 01 Jul 2022UK£269.5bUK£74.8bUK£4.6b16.6x59.1x3.6x
Sun, 29 May 2022UK£264.6bUK£73.4bUK£4.6b17.2x57.7x3.6x
Price to Earnings Ratio

57.7x


Total Market Cap: UK£264.6bTotal Earnings: UK£4.6bTotal Revenue: UK£73.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 35.1x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.6x which is lower than its 3-year average PE of 35.1x.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 33% per year over the last three years.
  • Revenues for these companies have grown 5.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market2.22%
Healthcare4.60%
Pharma4.85%
Pharma4.85%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£104.924.7%
+UK£7.3b		-15.1%PE28.1x
GSK GSKUK£14.305.1%
+UK£2.8b		-20.0%PE18.4x
HLN HaleonUK£4.144.9%
+UK£1.7b		24.9%PE25.8x
HIK Hikma PharmaceuticalsUK£20.787.1%
+UK£302.0m		7.2%PE17.1x
HCM HUTCHMED (China)UK£2.134.9%
+UK£85.5m		-31.9%PE64.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GSK

UK£14.30

GSK

7D

5.1%

1Y

-20.0%

AZN

UK£104.92

AstraZeneca

7D

4.7%

1Y

-15.1%

IMM

UK£0.029

ImmuPharma

7D

-17.1%

1Y

31.4%

POLB

UK£0.025

Poolbeg Pharma

7D

-13.8%

1Y

-81.1%

HCM

UK£2.13

HUTCHMED (China)

7D

4.9%

1Y

-31.9%

HIK

UK£20.78

Hikma Pharmaceuticals

7D

7.1%

1Y

7.2%

INDV

UK£8.44

Indivior

7D

0.4%

1Y

-36.3%

HLN

UK£4.14

Haleon

7D

4.9%

1Y

24.9%

Here's Why Haleon (LON:HLN) Can Manage Its Debt Responsibly

May 10
Here's Why Haleon (LON:HLN) Can Manage Its Debt Responsibly

ANCR

UK£2.55

Animalcare Group

7D

3.7%

1Y

4.5%

STX

UK£0.025

Shield Therapeutics

7D

-2.0%

1Y

19.5%

FUM

UK£0.08

Futura Medical

7D

-9.3%

1Y

-79.6%

INC

UK£0.055

Incanthera

7D

-4.3%

1Y

-70.3%

CEL

UK£0.045

Celadon Pharmaceuticals

7D

-10.0%

1Y

-95.5%

SAR

UK£0.15

Sareum Holdings

7D

-6.1%

1Y

-52.3%

ANA

UK£0.0032

Ananda Pharma

7D

-13.3%

1Y

44.4%